Market Outlook
The global Fluorescence-Guided Surgery Systems market size was valued at USD 84 million in 2022 and is forecast to a readjusted size of USD 351 million by 2029 with a CAGR of 22.6% during review period.
Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.
Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China. In terms of product, Only for Open Surgery is the largest segment, with a share over 86%. In terms of application, Cancer Surgeries is the largest market, with a share over 80%.
North America is the largest consumption place, with a consumption market share nearly 70% in 2019. Following North America, Europe is the second largest consumption place with 1/5 of the consumption market. Market competition is intense. Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ, etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global Fluorescence-Guided Surgery Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Fluorescence-Guided Surgery Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Fluorescence-Guided Surgery Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Fluorescence-Guided Surgery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Fluorescence-Guided Surgery Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fluorescence-Guided Surgery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fluorescence-Guided Surgery Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Stryker
Hamamatsu Photonics
Medtronic
Quest Medical Imaging
Shimadzu
Fluoptics
KARL STORZ
Segmentation By Type
Only for Open Surgery
System for Endoscopy
Segmentation By Application
Cancer Surgeries
Cardiovascular Surgeries
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Fluorescence-Guided Surgery Systems market in 2025?
The strengths include advanced imaging capabilities that enhance surgical precision, improving patient outcomes. The growing adoption of minimally invasive surgical techniques also supports market growth, as these systems align with the trend toward less invasive procedures.
What are the weaknesses in the Fluorescence-Guided Surgery Systems market in 2025?
Weaknesses include high initial costs for acquisition and maintenance, which may limit accessibility for smaller healthcare facilities. Additionally, the technology requires specialized training, which can pose a barrier to widespread adoption.
What opportunities exist for the Fluorescence-Guided Surgery Systems market in 2025?
Opportunities include increasing investments in healthcare infrastructure and research, driving the development of innovative technologies. Collaborations between technology companies and healthcare providers can also create new applications and expand market reach.
What threats could impact the Fluorescence-Guided Surgery Systems market in 2025?
Threats include potential regulatory challenges and the risk of technological obsolescence as new advancements emerge. Competitive pressures from alternative imaging technologies may also impact market share and growth.
Market PESTEL Analysis
What are the political factors affecting the Fluorescence-Guided Surgery Systems market in 2025?
Political factors include healthcare policy regulations, government funding for medical technologies, and approval processes by regulatory bodies. Political stability and healthcare reforms will impact market growth, especially in terms of access and reimbursement models for these technologies.
What economic factors influence the Fluorescence-Guided Surgery Systems market in 2025?
Economic factors such as the global economic climate, healthcare budgets, and the affordability of high-tech medical equipment play a role. Economic downturns may limit spending on advanced technologies, while increasing healthcare expenditure can foster growth in the market.
How do social factors impact the Fluorescence-Guided Surgery Systems market in 2025?
Social factors include the growing demand for minimally invasive surgery, which is driven by patients' preference for less painful and quicker recovery procedures. The rise in awareness of healthcare technology and its benefits also influences market adoption and demand.
What technological factors are shaping the Fluorescence-Guided Surgery Systems market in 2025?
Technological advancements in imaging systems, integration of AI for precision, and developments in fluorescence agents are key drivers. The increasing sophistication of these systems improves surgical outcomes and encourages their wider adoption.
What environmental factors affect the Fluorescence-Guided Surgery Systems market in 2025?
Environmental factors include sustainability concerns, such as the disposal of medical equipment and reducing the carbon footprint of healthcare facilities. The shift toward environmentally friendly and energy-efficient technologies could impact the market’s product development.
What legal factors impact the Fluorescence-Guided Surgery Systems market in 2025?
Legal factors include strict regulations on medical device approvals, intellectual property rights, and liability concerns. Compliance with international standards, such as FDA approvals, and patent laws for innovative technologies can influence the pace at which products enter the market.
Market SIPOC Analysis
Who are the suppliers in the Fluorescence-Guided Surgery Systems market in 2025?
Suppliers include manufacturers of fluorescence imaging systems, surgical instruments, and fluorescence agents. They also include technology providers for the integration of AI and software solutions that enhance the systems’ capabilities.
What inputs are required for the Fluorescence-Guided Surgery Systems market in 2025?
Inputs include cutting-edge imaging technologies, fluorescence agents, research and development resources, skilled workforce for manufacturing, and regulatory compliance expertise to meet the required medical standards.
What processes are involved in the Fluorescence-Guided Surgery Systems market in 2025?
Processes involve designing, manufacturing, and testing fluorescence-guided surgery systems, as well as regulatory approval processes. It also includes training healthcare professionals to use the technology and integrating it into medical procedures for surgical applications.
What are the outputs in the Fluorescence-Guided Surgery Systems market in 2025?
Outputs are advanced, high-performance fluorescence-guided surgery systems, along with associated training materials, support services, and software updates that improve surgical precision and patient outcomes.
Who are the customers in the Fluorescence-Guided Surgery Systems market in 2025?
Customers include hospitals, surgical centers, and healthcare providers adopting advanced medical technologies. This also includes research institutions and clinical trial organizations that aim to use the technology in specialized treatments and studies.
Market Porter's Five Forces
What is the threat of new entrants in the Fluorescence-Guided Surgery Systems market in 2025?
The threat of new entrants is moderate. While the market holds significant growth potential, the high capital investment required for research, development, and manufacturing, as well as the need for regulatory approvals, create barriers to entry.
What is the bargaining power of suppliers in the Fluorescence-Guided Surgery Systems market in 2025?
The bargaining power of suppliers is moderate to high. The market relies on specialized suppliers for advanced imaging technologies, fluorescence agents, and software solutions, which gives suppliers some influence over prices and availability.
What is the bargaining power of buyers in the Fluorescence-Guided Surgery Systems market in 2025?
The bargaining power of buyers is moderate. Healthcare providers can choose from several suppliers, but the specialized nature of the technology limits the number of options, and the high cost of systems reduces the negotiation leverage of buyers.
What is the threat of substitute products or services in the Fluorescence-Guided Surgery Systems market in 2025?
The threat of substitutes is low to moderate. While other imaging technologies like MRI and CT scans exist, fluorescence-guided surgery offers unique benefits in surgical precision and patient outcomes, making it difficult to replace directly.
What is the intensity of competitive rivalry in the Fluorescence-Guided Surgery Systems market in 2025?
The intensity of competitive rivalry is moderate. The market is growing, but competition among established players and new entrants is increasing. Companies are differentiating through technology advancements, product quality, and customer service to capture market share.
Market Upstream Analysis
What are the key suppliers in the Fluorescence-Guided Surgery Systems market in 2025?
Key suppliers include companies that manufacture fluorescence agents, imaging technologies (such as cameras, lasers, and sensors), and software providers that enable integration and data analysis for surgical precision.
What raw materials or components are essential for the Fluorescence-Guided Surgery Systems market in 2025?
Essential components include high-quality optical sensors, lasers, fluorescence dyes, specialized surgical tools, and software for data integration and real-time image processing.
What technological developments are influencing the upstream in the Fluorescence-Guided Surgery Systems market in 2025?
Technological advancements in high-definition imaging, AI-driven software for enhanced precision, and more effective fluorescence agents are pivotal in shaping the upstream. These developments drive innovation and improve the capabilities of fluorescence-guided surgery systems.
What are the regulatory and quality control requirements affecting upstream operations in the Fluorescence-Guided Surgery Systems market in 2025?
Regulatory requirements include compliance with medical device safety standards, FDA approvals, and ISO certifications. Stringent quality control processes are essential to ensure the safety, efficacy, and reliability of the systems, affecting both production and supply chain.
How do supply chain dynamics impact the Fluorescence-Guided Surgery Systems market in 2025?
Supply chain dynamics are influenced by the availability of raw materials, global trade policies, and logistics. Any disruption in the supply of essential components, such as advanced sensors or dyes, can lead to delays in production and increased costs.
Market Midstream Analysis
What are the key players in the midstream of the Fluorescence-Guided Surgery Systems market in 2025?
Key players include manufacturers of the integrated fluorescence-guided surgery systems, system integrators, and technology developers that combine imaging hardware, software, and fluorescence agents into cohesive surgical platforms.
What processes occur in the midstream of the Fluorescence-Guided Surgery Systems market in 2025?
Processes include the assembly of components, testing for system reliability and performance, and integration of software to enable real-time image analysis and enhanced surgical decision-making. Additionally, partnerships for distribution and service support are vital.
What are the challenges faced in the midstream of the Fluorescence-Guided Surgery Systems market in 2025?
Challenges include ensuring consistent quality across complex systems, managing the integration of multiple technologies, and maintaining compliance with evolving regulatory standards. Scalability and maintaining supply chain efficiency also present challenges.
How do pricing and cost structures impact the midstream in the Fluorescence-Guided Surgery Systems market in 2025?
Pricing and cost structures are influenced by the high cost of advanced imaging systems, research and development, and regulatory approval processes. These costs are passed on to healthcare providers, affecting adoption rates and market dynamics.
What role do partnerships and collaborations play in the midstream of the Fluorescence-Guided Surgery Systems market in 2025?
Partnerships between technology providers, medical device manufacturers, and healthcare institutions are crucial for enhancing product development, testing, and market access. These collaborations help drive innovation and improve system integration for better surgical outcomes.
Market Downstream Analysis
Who are the primary customers in the downstream of the Fluorescence-Guided Surgery Systems market in 2025?
Primary customers include hospitals, surgical centers, and outpatient clinics that utilize fluorescence-guided surgery systems to enhance surgical precision and patient outcomes. Additionally, research institutions involved in clinical trials also represent a significant customer segment.
What are the key applications of Fluorescence-Guided Surgery Systems in the downstream market in 2025?
Key applications include tumor visualization during cancer surgeries, real-time assessment of surgical margins, and identification of critical structures to minimize damage during procedures. These applications improve the accuracy and effectiveness of surgeries.
What factors influence customer adoption of Fluorescence-Guided Surgery Systems in the downstream market in 2025?
Factors influencing customer adoption include the demonstrated effectiveness of the technology in improving surgical outcomes, cost-effectiveness compared to traditional methods, ease of integration into existing surgical workflows, and the availability of training and support.
How do marketing and distribution strategies impact the downstream of the Fluorescence-Guided Surgery Systems market in 2025?
Effective marketing and distribution strategies are essential for educating healthcare providers about the benefits of fluorescence-guided surgery systems. Strong partnerships with medical device distributors and targeted marketing campaigns help drive awareness and facilitate access to these technologies.
What challenges do healthcare providers face when implementing Fluorescence-Guided Surgery Systems in the downstream market in 2025?
Healthcare providers face challenges such as high initial costs, the need for specialized training, and integration with existing surgical protocols and technologies. Additionally, navigating reimbursement processes for new technologies can be complex, impacting adoption rates.
Chapter 1, to describe Fluorescence-Guided Surgery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fluorescence-Guided Surgery Systems, with price, sales, revenue and global market share of Fluorescence-Guided Surgery Systems from 2018 to 2023.
Chapter 3, the Fluorescence-Guided Surgery Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fluorescence-Guided Surgery Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Fluorescence-Guided Surgery Systems market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescence-Guided Surgery Systems.
Chapter 14 and 15, to describe Fluorescence-Guided Surgery Systems sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Fluorescence-Guided Surgery Systems
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Fluorescence-Guided Surgery Systems Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Only for Open Surgery
1.3.3 System for Endoscopy
1.4 Market Analysis by Application
1.4.1 Overview: Global Fluorescence-Guided Surgery Systems Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer Surgeries
1.4.3 Cardiovascular Surgeries
1.4.4 Others
1.5 Global Fluorescence-Guided Surgery Systems Market Size & Forecast
1.5.1 Global Fluorescence-Guided Surgery Systems Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Fluorescence-Guided Surgery Systems Sales Quantity (2018-2029)
1.5.3 Global Fluorescence-Guided Surgery Systems Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Stryker
2.1.1 Stryker Details
2.1.2 Stryker Major Business
2.1.3 Stryker Fluorescence-Guided Surgery Systems Product and Services
2.1.4 Stryker Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Stryker Recent Developments/Updates
2.2 Hamamatsu Photonics
2.2.1 Hamamatsu Photonics Details
2.2.2 Hamamatsu Photonics Major Business
2.2.3 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product and Services
2.2.4 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Hamamatsu Photonics Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Fluorescence-Guided Surgery Systems Product and Services
2.3.4 Medtronic Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Quest Medical Imaging
2.4.1 Quest Medical Imaging Details
2.4.2 Quest Medical Imaging Major Business
2.4.3 Quest Medical Imaging Fluorescence-Guided Surgery Systems Product and Services
2.4.4 Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Quest Medical Imaging Recent Developments/Updates
2.5 Shimadzu
2.5.1 Shimadzu Details
2.5.2 Shimadzu Major Business
2.5.3 Shimadzu Fluorescence-Guided Surgery Systems Product and Services
2.5.4 Shimadzu Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Shimadzu Recent Developments/Updates
2.6 Fluoptics
2.6.1 Fluoptics Details
2.6.2 Fluoptics Major Business
2.6.3 Fluoptics Fluorescence-Guided Surgery Systems Product and Services
2.6.4 Fluoptics Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Fluoptics Recent Developments/Updates
2.7 KARL STORZ
2.7.1 KARL STORZ Details
2.7.2 KARL STORZ Major Business
2.7.3 KARL STORZ Fluorescence-Guided Surgery Systems Product and Services
2.7.4 KARL STORZ Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KARL STORZ Recent Developments/Updates
3 Competitive Environment: Fluorescence-Guided Surgery Systems by Manufacturer
3.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Manufacturer (2018-2023)
3.2 Global Fluorescence-Guided Surgery Systems Revenue by Manufacturer (2018-2023)
3.3 Global Fluorescence-Guided Surgery Systems Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Fluorescence-Guided Surgery Systems by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Fluorescence-Guided Surgery Systems Manufacturer Market Share in 2022
3.4.2 Top 6 Fluorescence-Guided Surgery Systems Manufacturer Market Share in 2022
3.5 Fluorescence-Guided Surgery Systems Market: Overall Company Footprint Analysis
3.5.1 Fluorescence-Guided Surgery Systems Market: Region Footprint
3.5.2 Fluorescence-Guided Surgery Systems Market: Company Product Type Footprint
3.5.3 Fluorescence-Guided Surgery Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Fluorescence-Guided Surgery Systems Market Size by Region
4.1.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2029)
4.1.2 Global Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2029)
4.1.3 Global Fluorescence-Guided Surgery Systems Average Price by Region (2018-2029)
4.2 North America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.3 Europe Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.4 Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.5 South America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.6 Middle East and Africa Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
5.2 Global Fluorescence-Guided Surgery Systems Consumption Value by Type (2018-2029)
5.3 Global Fluorescence-Guided Surgery Systems Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
6.2 Global Fluorescence-Guided Surgery Systems Consumption Value by Application (2018-2029)
6.3 Global Fluorescence-Guided Surgery Systems Average Price by Application (2018-2029)
7 North America
7.1 North America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
7.2 North America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
7.3 North America Fluorescence-Guided Surgery Systems Market Size by Country
7.3.1 North America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
7.3.2 North America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
8.2 Europe Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
8.3 Europe Fluorescence-Guided Surgery Systems Market Size by Country
8.3.1 Europe Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
8.3.2 Europe Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Fluorescence-Guided Surgery Systems Market Size by Region
9.3.1 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
10.2 South America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
10.3 South America Fluorescence-Guided Surgery Systems Market Size by Country
10.3.1 South America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
10.3.2 South America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Fluorescence-Guided Surgery Systems Market Size by Country
11.3.1 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Fluorescence-Guided Surgery Systems Market Drivers
12.2 Fluorescence-Guided Surgery Systems Market Restraints
12.3 Fluorescence-Guided Surgery Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Fluorescence-Guided Surgery Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fluorescence-Guided Surgery Systems
13.3 Fluorescence-Guided Surgery Systems Production Process
13.4 Fluorescence-Guided Surgery Systems Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Fluorescence-Guided Surgery Systems Typical Distributors
14.3 Fluorescence-Guided Surgery Systems Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Fluorescence-Guided Surgery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Fluorescence-Guided Surgery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Stryker Basic Information, Manufacturing Base and Competitors
Table 4. Stryker Major Business
Table 5. Stryker Fluorescence-Guided Surgery Systems Product and Services
Table 6. Stryker Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Stryker Recent Developments/Updates
Table 8. Hamamatsu Photonics Basic Information, Manufacturing Base and Competitors
Table 9. Hamamatsu Photonics Major Business
Table 10. Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product and Services
Table 11. Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Hamamatsu Photonics Recent Developments/Updates
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Major Business
Table 15. Medtronic Fluorescence-Guided Surgery Systems Product and Services
Table 16. Medtronic Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Medtronic Recent Developments/Updates
Table 18. Quest Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 19. Quest Medical Imaging Major Business
Table 20. Quest Medical Imaging Fluorescence-Guided Surgery Systems Product and Services
Table 21. Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Quest Medical Imaging Recent Developments/Updates
Table 23. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 24. Shimadzu Major Business
Table 25. Shimadzu Fluorescence-Guided Surgery Systems Product and Services
Table 26. Shimadzu Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shimadzu Recent Developments/Updates
Table 28. Fluoptics Basic Information, Manufacturing Base and Competitors
Table 29. Fluoptics Major Business
Table 30. Fluoptics Fluorescence-Guided Surgery Systems Product and Services
Table 31. Fluoptics Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Fluoptics Recent Developments/Updates
Table 33. KARL STORZ Basic Information, Manufacturing Base and Competitors
Table 34. KARL STORZ Major Business
Table 35. KARL STORZ Fluorescence-Guided Surgery Systems Product and Services
Table 36. KARL STORZ Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KARL STORZ Recent Developments/Updates
Table 38. Global Fluorescence-Guided Surgery Systems Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 39. Global Fluorescence-Guided Surgery Systems Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Fluorescence-Guided Surgery Systems Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Fluorescence-Guided Surgery Systems, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Fluorescence-Guided Surgery Systems Production Site of Key Manufacturer
Table 43. Fluorescence-Guided Surgery Systems Market: Company Product Type Footprint
Table 44. Fluorescence-Guided Surgery Systems Market: Company Product Application Footprint
Table 45. Fluorescence-Guided Surgery Systems New Market Entrants and Barriers to Market Entry
Table 46. Fluorescence-Guided Surgery Systems Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2023) & (Units)
Table 48. Global Fluorescence-Guided Surgery Systems Sales Quantity by Region (2024-2029) & (Units)
Table 49. Global Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Fluorescence-Guided Surgery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Fluorescence-Guided Surgery Systems Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Fluorescence-Guided Surgery Systems Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 54. Global Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 55. Global Fluorescence-Guided Surgery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Fluorescence-Guided Surgery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Fluorescence-Guided Surgery Systems Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Fluorescence-Guided Surgery Systems Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 60. Global Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 61. Global Fluorescence-Guided Surgery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Fluorescence-Guided Surgery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Fluorescence-Guided Surgery Systems Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Fluorescence-Guided Surgery Systems Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 66. North America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 67. North America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 68. North America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 69. North America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2023) & (Units)
Table 70. North America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2024-2029) & (Units)
Table 71. North America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Fluorescence-Guided Surgery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 74. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 75. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 76. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 77. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2023) & (Units)
Table 78. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Country (2024-2029) & (Units)
Table 79. Europe Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Fluorescence-Guided Surgery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 82. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 83. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 84. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 85. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2023) & (Units)
Table 86. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Region (2024-2029) & (Units)
Table 87. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 90. South America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 91. South America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 92. South America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 93. South America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2023) & (Units)
Table 94. South America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2024-2029) & (Units)
Table 95. South America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Fluorescence-Guided Surgery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 98. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 99. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 100. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 101. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2023) & (Units)
Table 102. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Region (2024-2029) & (Units)
Table 103. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Fluorescence-Guided Surgery Systems Raw Material
Table 106. Key Manufacturers of Fluorescence-Guided Surgery Systems Raw Materials
Table 107. Fluorescence-Guided Surgery Systems Typical Distributors
Table 108. Fluorescence-Guided Surgery Systems Typical Customers
List of Figures
Figure 1. Fluorescence-Guided Surgery Systems Picture
Figure 2. Global Fluorescence-Guided Surgery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Type in 2022
Figure 4. Only for Open Surgery Examples
Figure 5. System for Endoscopy Examples
Figure 6. Global Fluorescence-Guided Surgery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Application in 2022
Figure 8. Cancer Surgeries Examples
Figure 9. Cardiovascular Surgeries Examples
Figure 10. Others Examples
Figure 11. Global Fluorescence-Guided Surgery Systems Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Fluorescence-Guided Surgery Systems Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Fluorescence-Guided Surgery Systems Sales Quantity (2018-2029) & (Units)
Figure 14. Global Fluorescence-Guided Surgery Systems Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Fluorescence-Guided Surgery Systems by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Fluorescence-Guided Surgery Systems Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Fluorescence-Guided Surgery Systems Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Fluorescence-Guided Surgery Systems Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Fluorescence-Guided Surgery Systems Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Fluorescence-Guided Surgery Systems Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Fluorescence-Guided Surgery Systems Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value Market Share by Region (2018-2029)
Figure 53. China Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Fluorescence-Guided Surgery Systems Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Fluorescence-Guided Surgery Systems Market Drivers
Figure 74. Fluorescence-Guided Surgery Systems Market Restraints
Figure 75. Fluorescence-Guided Surgery Systems Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Fluorescence-Guided Surgery Systems in 2022
Figure 78. Manufacturing Process Analysis of Fluorescence-Guided Surgery Systems
Figure 79. Fluorescence-Guided Surgery Systems Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source